Hsp90α as a promising therapeutic target for suppressing tumor progression in Lactotroph PitNETs
Molecular and Cellular Endocrinology · 2026
DOI: 10.1016/j.mce.2026.112733 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular and Cellular Endocrinology, 2026. Verfasst von Jie Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The first Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, Xinjiang, China. Hauptthemen laut MEDLINE: HSP90 Heat-Shock Proteins, Neuroendocrine Tumors, Lactotrophs, Disease Progression. Die Arbeit nennt 68 Literaturangaben. Gefördert von: Xinjiang Uygur Autonomous Region Natural Science Foundation.
Abstract (Originalsprache)
BACKGROUND: Aggressive Lactotroph Pituitary Neuroendocrine Tumors (Lactotroph PitNETs) usually exhibit invasive growth behavior and resistance to dopamine agonists, showing difficulty in radical treatment and a high recurrence rate. Heat shock protein 90α(Hsp90α),a pivotal isoform of the heat shock protein 90(Hsp90) family, acts as a central chaperone that stabilizes numerous oncoproteins driving tumor progression, but its role in Lactotroph PitNETs remains unclear. OBJECTIVE: To study the effect of Hsp90α knockdown on the proliferation and invasiveness of Lactotroph PitNETs cells (MMQ). METHODS: Hsp90α and EGFR expression was compared between 18 aggressive and 22 Non-Aggressive human Lactotroph PitNETs by IHC and immunofluorescence. MMQ rat lactosomatotroph cells were transduced with lentiviral shRNA targeting Hsp90α(shHsp90α). Cell proliferation (CCK8),apoptosis (Annexin-V/7-AAD flow cytometry), Prolactin (PRL) secretion (ELISA), migration and invasion (Transwell) were assessed. Western blotting evaluated EGFR,PRL,AKT,ERK1/2,mTOR,p-AKT,p-ERK1/2 and p-mTOR. RESULTS: Aggressive Lactotroph PitNETs displayed higher Hsp90α and EGFR expression and showed a notable degree of spatial overlap. Hsp90α knockdown reduced EGFR,AKT,ERK1/2,mTOR,p-AKT,p-ERK1/2 and p-mTOR levels, decreased proliferation, increased apoptosis, lowered PRL secretion, and impaired migration and invasion. CONCLUSIONS: Hsp90α knockdown simultaneously destabilizes EGFR and its downstream AKT/mTOR and ERK axes, resulting in multi-modal suppression of Lactotroph PitNETs invasion. Targeting Hsp90α may offer a novel therapeutic strategy for Aggressive Lactotroph PitNETs refractory to standard medical therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, The first Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, Xinjiang, China.
- Department of Neurosurgery, The first Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, Xinjiang, China. Electronic address: lss8091@163.com.
Förderung
- Xinjiang Uygur Autonomous Region Natural Science Foundation
Zitieren
APA
Wu, J., Zhou, Z., Ding, C., Sun, H., Xia, M., Zhou, K., Zhang, T., & Li, S. (2026). Hsp90α as a promising therapeutic target for suppressing tumor progression in Lactotroph PitNETs. Molecular and Cellular Endocrinology. https://doi.org/10.1016/j.mce.2026.112733
Vancouver
Wu J, Zhou Z, Ding C, Sun H, Xia M, Zhou K, et al. Hsp90α as a promising therapeutic target for suppressing tumor progression in Lactotroph PitNETs. Molecular and Cellular Endocrinology. 2026. doi:10.1016/j.mce.2026.112733
BibTeX
@article{Wu2026,
author = {Wu, Jie and Zhou, Zhengan and Ding, Chongxue and Sun, Hongjie and Xia, Ming and Zhou, Kai and Zhang, Tingrong and Li, Shaoshan},
title = {Hsp90α as a promising therapeutic target for suppressing tumor progression in Lactotroph PitNETs},
journal = {Molecular and Cellular Endocrinology},
year = {2026},
doi = {10.1016/j.mce.2026.112733}
}
EUVIMED